Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucarpidase for Delayed Methotrexate Clearance in ALL
NCT01305655Phase 3Completed
- Sponsor
- Nordic Society for Pediatric Hematology and Oncology
- Start
- Jul 2008
- Primary completion
- Dec 2014
- Modality
- Replacement Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of glucarpidase in acute lymphoblastic leukemia (ALL), sponsored by Nordic Society for Pediatric Hematology and Oncology. Started Jul 2008; status: completed.
02
Drugs
glucarpidase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01305655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305655.